Search tips
Search criteria 


Logo of plosntdPLoS Neglected Tropical DiseasesView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS Negl Trop Dis. 2010 April; 4(4): e653.
Published online 2010 April 6. doi:  10.1371/journal.pntd.0000653
PMCID: PMC2850316

A Systems-Based Analysis of Plasmodium vivax Lifecycle Transcription from Human to Mosquito

Rhoel Ramos Dinglasan, Editor



Up to 40% of the world's population is at risk for Plasmodium vivax malaria, a disease that imposes a major public health and economic burden on endemic countries. Because P. vivax produces latent liver forms, eradication of P. vivax malaria is more challenging than it is for P. falciparum. Genetic analysis of P. vivax is exceptionally difficult due to limitations of in vitro culture. To overcome the barriers to traditional molecular biology in P. vivax, we examined parasite transcriptional changes in samples from infected patients and mosquitoes in order to characterize gene function, define regulatory sequences and reveal new potential vaccine candidate genes.

Principal Findings

We observed dramatic changes in transcript levels for various genes at different lifecycle stages, indicating that development is partially regulated through modulation of mRNA levels. Our data show that genes involved in common biological processes or molecular machinery are co-expressed. We identified DNA sequence motifs upstream of co-expressed genes that are conserved across Plasmodium species that are likely binding sites of proteins that regulate stage-specific transcription. Despite their capacity to form hypnozoites we found that P. vivax sporozoites show stage-specific expression of the same genes needed for hepatocyte invasion and liver stage development in other Plasmodium species. We show that many of the predicted exported proteins and members of multigene families show highly coordinated transcription as well.


We conclude that high-quality gene expression data can be readily obtained directly from patient samples and that many of the same uncharacterized genes that are upregulated in different P. vivax lifecycle stages are also upregulated in similar stages in other Plasmodium species. We also provide numerous examples of how systems biology is a powerful method for determining the likely function of genes in pathogens that are neglected due to experimental intractability.

Author Summary

Most of the 250 million malaria cases outside of Africa are caused by the parasite Plasmodium vivax. Although drugs can be used to treat P. vivax malaria, drug resistance is spreading and there is no available vaccine. Because this species cannot be readily grown in the laboratory there are added challenges to understanding the function of the many hypothetical genes in the genome. We isolated transcriptional messages from parasites growing in human blood and in mosquitoes, labeled the messages and measured how their levels for different parasite growth conditions. The data for 5,419 parasite genes shows extensive changes as the parasite moves between human and mosquito and reveals highly expressed genes whose proteins might represent new therapeutic targets for experimental vaccines. We discover sets of genes that are likely to play a role in the earliest stages of hepatocyte infection. We find intriguing differences in the expression patterns of different blood stage parasites that may be related to host-response status.


Renewed efforts to combat malaria have focused on the goal of total eradication. While most attention is on the more deadly Plasmodium falciparum malaria, Plasmodium vivax is the most geographically widespread human malaria parasite causing an estimated 80–250 million cases of vivax malaria each year [1]. P. vivax malaria has traditionally been found outside of tropical areas and was endemic throughout North America and Europe until the introduction of DDT. Despite the large burden of disease caused by P. vivax, it is overlooked and left in the shadow of the enormous public health burden caused by P. falciparum in sub-Saharan Africa. The widely held misperception of P. vivax as being relatively infrequent, benign, and easily treated explains it's nearly complete neglected across the range of biological and clinical research. In fact, P. vivax malaria seriously threatens more people than has been historically appreciated. Recent reports [2][4] provide abundant evidence that challenge the paradigm that P. vivax infection causes benign disease: P. vivax malaria may result in severe symptoms similar to P. falciparum. Selective pressure for resistance to malaria has had a great influence on the human genome and most Africans are immune to P. vivax malaria due to mutations in the Duffy receptor that the parasites use to invade the red cell.

A fundamental difference between P. vivax and P. falciparum is the formation of dormant liver stage parasites called hypnozoites that are resistant to schizonticidal drugs that kill erythrocytic stage parasites. Despite schizonticidal drug therapy, the patient may experience multiple relapses months or years following the primary infection. Attempts to eradicate malaria will depend on having effective and non-toxic drugs that target P. vivax liver stage hypnozoites. Hypnozoite biology is poorly understood but is likely related to persistence of the parasite in locales where mosquito populations vary seasonally. Little is known about what triggers a relapse but some strains form different numbers of hypnozoites and have different relapse frequencies, which may be correlated with latitude[5]. There is controversy about whether hypnozoites represent a different lifecycle stage or merely represent an arrested early exo-erythrocytic phase. Almost nothing is known about metabolic activity in the hypnozoite, thwarting all efforts at rationale drug design. The mechanism of the only drug known to eradicate hypnozoites, the 8-aminoquinoline drug, primaquine, is still not completely understood.

While rodent models have furthered our understanding of Plasmodium liver stage development, they do not form hypnozoites. The only other available model for studying hypnozoite biology is the closely related P. cynomolgi species that must be studied in the rhesus macaque. Studies of P. vivax biology still depend on obtaining erythrocyte stage parasites or sporozoites from infected humans or non-human primates or their mosquito vectors, respectively. Drug sensitivity testing remains difficult. In an earlier era compounds were tested for activity against hypnozoites in prisoners who had been given malaria [6]. Drug testing in vitro is limited by current difficulties in culture techniques. Only a few genetic manipulations of P. vivax have been successful [7]. These impediments have discouraged many researchers from working on P. vivax, and limited the potential for molecular genetic analysis of this elusive liver stage.

Given that forward and reverse genetic methods, which have been powerful in P. falciparum, are not readily available for investigating the genome of P. vivax, comparative genomics and virtual genetic methods offer the best opportunities to elucidate P. vivax gene function. Previous gene expression profiling of P. falciparum [8], [9] P. yoelii [10] throughout many developmental life cycle stages in the mammalian host and insect vector, and in P. vivax blood stages [11], [12] has provided fundamental insight into Plasmodium biology and illustrated how gene function can be predicted based on gene expression patterns throughout development. The power of this method is to assure that there is sufficient diversity in different stage parasites to allow for the delineation of distinct patterns of gene expression.

Here we used a systems biology approach to characterize the P. vivax transcriptome. Using a custom high-density tiling microarray, we obtained a diverse set of gene expression data from human and mosquito stages including sporozoites, gametes, zygotes and ookinetes, and in vivo asexual blood stages obtained from infected patients in the Peruvian Amazon. These data are combined with published short term in vitro culture data [11]. Using a guilt-by-association approach we create hypotheses about the function of many uncharacterized genes. Comparison to datasets of P. falciparum and P. yoelii reveals conserved and species-specific patterns. This analysis provides new insights into the metabolic state of parasites growing within humans. It shows that many of the orthologs of P. falciparum transcripts needed for exo-erythrocytic development are present in the P. vivax sporozoites suggesting that slight modifications in exo-erythrocytic development may allow hypnozoite formation.

Materials and Methods

Ethics statement

The protocol used to collect human blood samples for this work was approved by the Human Subjects Protection Program of The Scripps Research Institute, and the University of California, San Diego and by the Ethical Committees of Universidad Peruana Cayetano Heredia and Asociacion Benefica PRISMA, Iquitos, Peru. Written informed consent was obtained from each subject or the parent, in the case of minors. The consent form states in English and Spanish that samples may be used for any scientific purpose involving this or any other project, now or in the future and that the samples may be shared with other researchers.

Collection of patient samples and preparation of parasite cells

Patients who presented to local health clinics in the Peruvian Amazon region of Iquitos with typical signs and symptoms of malaria were evaluated by light microscopy examination of Giemsa-stained blood smears to have P. vivax parasitemia. After informed consent, 20 ml of blood was drawn into heparinized vaccutainer tubes, placed in a portable incubator maintained between 37 and 39°C, and transported to laboratory facilities within 30 minutes. Blood was centrifuged at 900×g for 5 minutes and plasma was removed. Red cells were resuspended in 2 volumes of suspended animation (SA) solution (10 mM Tris, 170 mM NaCl, and 10 mM glucose pH 7.4) and passed through a cellulose column (CF-11 powder, Whatman Ltd) placed in a 37°C incubator, to remove white blood cells. Asexual parasites were enriched by gradient purification. Following filtration, cells were washed twice in SA solution at 900 g for 5 minutes and then resuspended in a 1[ratio]3 v/v ratio in SA solution. For the production of gametes/zygotes and ookinetes in vitro, The red cells containing parasites were resuspended in exflagellation medium (10 mM Tris, 170 mM NaCl, 10 mM glucose, 25 mM NaCO3, 10% AB+ human serum, 50 mM xanthurenic acid) to induce parasite emergence from gametocytes, exflagellation and fertilization. The cell suspension was then layered over a discontinuous gradient of 38%, 42% and 50% Percoll (Sigma, USA) in RPMI 1640 medium (Invitrogen USA) and centrifuged at 600 g for 15 minutes. Female gametocytes at the 38–42% interface were removed from the gradient. Red cells containing asexual parasites which sediment below the gradient were collected and washed separately in SA solution at 900 g for 10 minutes. Zygotes and ookinetes and untransformed gametes at the 11%–16% interface were collected, washed in PBS and resuspended in Trizol and stored at −70°C. Microscopic analysis of cellular morphology confirmed the enrichment of sexual stages. Small aliquots of purified cells were stained and 60 fields were examined to determine the relative percentage of asexual and gametocyte cells (Table 1). Red cells from asexual enrichments were subjected to lysis by a 0.1% Saponin solution in PBS for 15 minutes at 4°C. Parasites were pelleted at 1200 g for 5 minutes and washed three times in PBS before resuspension in Trizol and storage at −70°C for shipment to the Scripps Research Institute.

Table 1
P. vivax blood sample asexual profile and stage specificity.

P. vivax whole genome-tiling microarray design

We designed a Affymetrix custom P. vivax whole-genome tiling microarray with 4.2 million 25-bp probes covering both strands at six base pair spacing, based on the genome assembly of 2809 contigs (PlasmoDB Ver. 5.4). This microarray includes 1.7 and 2.3 million probes uniquely mapped to coding regions and non-coding regions, respectively. Altogether 5419 P. vivax genes are represented on the array, 4676 of which have P. falciparum orthologs. This array will be made available for purchase from Affymetrix, part number PvivaxLi520507.

RNA preparation and microarray hybridization

RNA was purified by Chloroform extraction and isopropanol precipitation and purified by RNeasy Mini Kit (Qiagen) following the manufacturer's instructions. RNA was quantified by spectrophotometer and qualitatively analyzed by BioRad Experion RNA StdSens Analysis kit (BioRad). 1 ug of total RNA from asexual blood stage parasites was used to produce cDNA in the Two-cycle cDNA synthesis kit (Affymetrix) and amplified to produce labeled cRNA in the IVT Labeling kit (Affymetrix), and purified using the Genechip Sample Cleanup Module (Affymetrix), according to manufacturer's instructions. For the sporozoite sample, 100 ng of total RNA was used to produce cDNA in the Two-cycle cDNA synthesis kit (Affymetrix) and amplified to produce labeled cRNA in the IVT T7 MEGAScript kit (Affymetrix). Following the first IVT reaction, the cRNA was split into two reactions, containing approximately 500 ng each for the second round of cDNA synthesis and amplified to produce labeled cRNA in the IVT Labeling kit (Affymetrix), and purified using the Genechip Sample Cleanup Module (Affymetrix), according to manufacturer's instructions. 20 ug of amplified cRNA was hybridized to the P. vivax tiling microarray for 14 hours. The genechips were washed on Affymetrix Wash Station using standard Affymetrix protocol FlexGE-WS450_00001 and scanned on the Affymetrix scanner. The Affymetrix CEL files microarray data are available for download from our companion website ( Gene expression data are also visible in PlasmoDB on the P. vivax gene info pages. For more information on gene expression interpretation from our custom whole genome tiling array please see the website.

Differential gene expression and OPI analysis

All gene expression values were subjected to a probe-level two-way ANOVA test to determine variability of expression across all samples [13]. A total of 4,326 genes were identified as differentially expressed with pANOVA <0.05 and FC >2 (Table S1) and were subjected to further OPI clustering analysis. All data can be downloaded from the companion web site.

All Plasmodium gene descriptions and name aliases were downloaded from PlasmoDB (version 6.1). Function annotation data for P. falciparum, P. yoelii, P. vivax, P. berghei, P. chaubaudi and P. knowlesi were obtained from PlasmoDB, then merged with P. falciparum function annotation data from Gene Ontology (November 2009 release). We had previously collected gene co-citation data through Google Scholar and NCBI [10], this dataset is appended with co-citation data found in “gene notes” section of the PlasmoDB annotation files. We also considered previously published data such as P. falciparum protein complexes [14], P. falciparum cell cycle k-means clusters [9], and our own literature-based annotations [10]. For each gene list, we further recruited additional gene members that are homologs or orthologs among Plasmodium species according to the latest OrthoMCL database (version 3). The final annotation database contains 3,732 gene lists that contains at least one P. vivax gene, including 2,538 GO groups, 1,066 literatures, 84 custom GNF lists, 29 complexes and 15 cell cycle clusters. From these 2,002 lists contains at least two differentially expressed P. vivax genes, therefore were used to create clusters of co-regulated genes that share gene ontology annotation using the ontology-based pattern identification (OPI) algorithm described previously [15]-[17]. To weight samples correctly, replicate samples were weighted 50% each and effected counted as one sample. When our dataset were merged with Bodzech data, the overall weighting of samples in each data set was adjusted so that two data sets contributed equally in the clustering analysis.

Visualization of the OPI expression patterns in Figure 1 used the OPI query pattern data as described previously [17]. Briefly, the query pattern is the best representative expression pattern of a given cluster, and was typically derived from common pattern shared by most of the known GO members of the cluster. Each query profile is normalized by subtracting the mean and divided by the standard deviation, a standard practice used for heat map plotting. The query patterns representing the 192 gene functions were hierarchically clustered so that related biological processes are close to each other.

Figure 1
Gene expression patterns of 192 statistically significant cellular function clusters across all 41 P. vivax samples.

Cross validation with published gene expression datasets

For each of the 192 statistically significant P. vivax OPI clusters, we identified the P. falciparum and P. yoelii orthologs of its cluster members. We then calculated the average pair-wise Pearson correlation coefficient of the P. falciparum orthologs in a previously published cell cycle dataset of 2,235 genes. The correlation coefficients are almost all positive with a median at 0.45. We also calculated using a similar approach the average correlation coefficients of the orthologs in a combined P. yoelii and P. falciparum life cycle dataset. All results are available in Table S2.

For each piece of P. vivax gene function prediction, we checked if its P. falciparum or P. yoelii orthologs were also predicted to be in the same function category based on the previous P. yoelii and P. falciparum life cycle dataset. Both previously published OPI clusters [10] and new OPI clusters based on the latest gene annotation database were used in this cross validation analyses. Notice here an orthlog was considered to be associated with a GO group as long as it appeared in the group or one of its descendant groups. Support was found for 89 of the 192 OPI clusters.

Cross validation with published yeast two-hybrid and literature datasets

We first projected the previously published P. falciparum yeast two-hybrid protein interaction database into P. vivax by introducing interactions to all the corresponding P. vivax ortholog pairs using OrthoMCL version 3. We then constructed a protein network for each OPI cluster and recorded the size of the network. To evaluate the statistical significance of the resultant network, we replaced the cluster members through random sampling and repeated the network construction process 1000 times. The p-value of the network was estimated based on the probability of an equal or more complex network to occur by chance. The whole process was carried out by either only considering direct protein-protein interactions or including indirect protein-protein interactions and whichever led to a better p-value was selected for presentation. An indirect protein-protein interaction refers to two proteins interact via another protein. A total of 63 networks were determined to have p-values <0.05.

It was previously shown that genes co-cited in a literature tend to be more correlated in their expression profile compared to gene members of the same GO group, probably due to the careful review process involved in the publication [10]. Therefore, it could be worthwhile introducing virtual protein-protein interactions among genes co-cited. With these virtual interactions appended to the yeast two-hybrid dataset, we repeated the above network evaluation processes for non-literature derived OPI clusters and identified 11 additional networks.

Protein networks were visualized using Cytoscape (Version 6.1), where nodes can be color coded according to the level of confidence in their function predictions, and edges can be color coded to reflect the data sources.

Motif analysis

Statistical enrichment of motifs in upstream regions was determined using GeneSpring 7.3 software, using the “search for regulatory sequences” with parameters of 0 to 1000 bases, motif sizes of 5 to 9 bps and allowing for up to two N's in the central region. Only cutoffs with a corrected p-value of less than 0.05 are reported except for very small clusters.

Preparation and analysis of P. yoelii and P. falciparum sporozoite RNA

P. vivax sporozoites were obtained from Sanaria, Inc. from mosquitoes fed on P. vivax infected chimpanzees infected with India VII strain P. vivax [18]. Sporozoites were dissected from mosquito salivary glands and purified. Approximately 150,000 sporozoite cells were used for RNA preparation. Similarly purified sporozoites of P. falciparum strain 3D7 isolated from mosquitoes infected with in vitro cultured parasites were also obtained from Sanaria, Inc.

P. falciparum salivary gland sporozoites were obtained from Sanaria, Inc. P. falciparum sporozoite RNA was isolated and amplified using Affymetrix kits as described for P. vivax sporozoite samples. P. falciparum 3D7 strain RNA from in vitro synchronized trophozoite stage parasites was isolated and amplified as described for P. vivax samples. Amplified cRNA was hybridized to the Pftiling array described previously [19].

To validate the expression comparison of genes that are differentially expressed in sporozoites of P. vivax and P. falciparum, we performed quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) on 22 genes with orthologs in both species, and two P. vivax specific genes. Primers used are listed below. All primer sets were optimized using genomic DNA from 3D7 strain P. falciparum and Salvador I strain P. vivax at three dilutions of 10 ng/ul, 1 ng/ul and 0.1 ng/ul to ensure that the amplification threshold values accurately reflected the difference in DNA template concentration. Primer sets for the two different species produced similar threshold Ct values (what does Ct stands for) (+/− 1.5 Ct) for all primer sets for both species. An additional aliquot of 150,000 sporozoites for both P. falciparum and P. vivax from Sanaria, Inc, were used to isolate total RNA using Trizol as described previously. This total RNA sample was split into equally into three reactions to produce single stranded cDNA using reverse transcriptase and a T7-Oligo dT primer from the cDNA synthesis kit (Affymetrix) according to manufacturer's instructions. The single stranded cDNA was used as template for QRT-PCR reactions using the primer sets presented. To account for variability in the input cDNA between different cDNA reactions from the same species, we normalized the threshold Ct values by the average difference between reactions across all genes. We cannot know the identity of any one gene, which is expressed at the exact same level in both species that can be used to control for variation. However, when comparing P. vivax and P. falciparum threshold Ct values, we found that the highest expressed gene (CSP) and lowest expressed gene (Pv117045 zinc finger) in both species showed very similar threshold Ct values within 1.5 Ct cycles, which was the within the error observed by DNA optimization. Our gene expression data from multiples species, including P. yoelii, as well as proteomic data and conventional experiments show CSP is often one of the most abundant proteins in plasmodium sporozoites. It seems safe to use this in normalization. qRT-PCR reactions were prepared using SYBR GREEN PCR Master Mix (Applied Biosystems) according to manufacturer's instructions, and were run on Applied Biosystems TaqMan machine using SDS 2.2.1 software. Threshold Ct values were determined using default settings and automatic threshold determination. All amplification results were manually inspected to ensure that threshold levels were determined within the logarithmic amplification phase of the reaction for accurate determination of Ct values. Fold difference between P. falciparum and P. vivax qRT-PCR determined expression values are equal to 2 raised to the power of the difference in Ct values between the two species. qRT-PCR results and primers used are listed in Supplemental Table S2.

The list of P. vivax sporozoite-specific genes used to seed the OPI cluster includes: S13, MAC/Perforin (PVX_000810, PFD0430c); SIAP-1 (PVX_000815, PFD0425w); pf52 protein (PVX_001015, PVX_001020, PFD0215c); ECP1, cysteine protease (PVX_003790, PFB0325c); asparagine-rich antigen Pfa35-2 (PVX_081485, PFA0280w); S24, hypothetical protein (PVX_081555, PFA0205w); TRSP (PVX_081560, PFA0200w); TRAP (PVX_082735, PF13_0201); S14, hypothetical protein (PVX_084410, PFL0370w); S25, kinesin-related protein (PVX_084580, PFL0545w); MAEBL (PVX_092975, PF11_0486); S1, hypothetical protein (PVX_094625, PF10_0083); kinesin-related protein (PVX_094710, PFL0545w); conserved hypothetical protein (PVX_097795, PFE0230w); hypothetical protein (PVX_118360, PF14_0404); circumsporozoite (CS) protein (PVX_119355, PFC0210c); early transcribed membrane protein 13, ETRAMP13 (PVX_121950, PF13_0012); S23, conserved hypothetical protein (PVX_123155, PF08_0088); S4, conserved hypothetical protein (PVX_123510, PFL0800c); conserved hypothetical protein (PVX_123750, PFL1075w).

Discovery of un-annotated gene expression in P. vivax

To infer gene expression of un-annotated genes in P. vivax, we performed a BLAST search of all P. falciparum and P. knowlesi annotated genes against the P. vivax genome to identify all putative orthologous genes that may not be annotated in P. vivax. The BLAST similarity coordinates were used to define the coding region in P. vivax. We have not validated the coding sequence for proper gene translation nor have we defined intron-exon boundaries for these genes. These gene boundary definitions were used to pick probes to evaluate the level of gene expression from these regions in the same way as all other annotated P. vivax genes. These genes were originally named using the GeneID numbers of their P. falciparum and P. knowlesi orthologs. We have included these gene expression values for these putative genes in Table S1. We also performed an analysis of all P. vivax RNA microarray hybridization data to identify highly transcribed regions of 50 bp that do not overlap with existing gene annotations. We found a few of these regions, but they appeared to correspond to additional exons, intronic regions, or 5′ or 3′ untranslated regions of existing genes. One additional gene identified by this method is the Pv_PF11_0140 gene. We provide putative P. vivax Gene ID numbers for these genes based on their position relative to existing flanking genes. We provide a list of these new putative gene coordinates in Supplemental Table S3.


Sample collection and microarray analysis

Blood samples were collected from eight different P. vivax-infected patients with uncomplicated malaria in Iquitos, Peru. Human leukocytes were removed by filtration and P. vivax gametocytes were separated from asexual stage parasites by gradient centrifugation. There was only a small proportion of gametocytes (0–15%) in the final sample (Table 1), so we hereafter refer to these samples as asexual profiles. By microscopy the asexual cells in the patient blood samples appeared to be rings and early trophozoite stages, with no late trophozoite or schizont stages, likely as the result of natural synchronization in the Peruvian patients. For one sample, we put the isolated gametocyte stages into in vitro culture and induced sexual stage development to obtain a mixed gamete/zygote stage sample and a mostly pure ookinete stage sample from the patient isolate (Table 1). Additionally, we isolated salivary gland sporozoites from dissected mosquitoes fed on an experimentally infected chimpanzee.

We assayed gene expression using a custom P. vivax whole genome tiling microarray with 4.2 million 25-base pair probes covering both strands at six base pair spacing. A semi-quantitative estimate of transcript abundance for each gene could be obtained with this microarray design because the 5,419 P. vivax genes were probed by hundreds of independent oligonucleotides. While this array can be used to find noncoding RNAs, including antisense RNAs, the labeled cRNA for hybridization was prepared using a polyA reverse transcriptase priming method that would not give accurate descriptions of noncoding RNAs and thus we limited our analysis to predicted coding regions. In order to calculate an approximate gene expression level, E, we used the MOID algorithm, which ranks the probe intensity values for the 20 probes at the 3′ end of the transcript having similar GC values. It then assigns the expression value, E, to difference between the background (computed from thousands of probes with a similar GC content not predicted to be in the P. vivax or human genome) and the probe at the 70th percentile (Table S1). Because the varying GC content of different P. vivax genes could give rise to spurious apparent expression levels, extensive optimization of probe selection was undertaken to ensure robust measurements of gene expression across all samples. We show that MOID expression values are not changed by selection of the independent 13th or 14th of 20 ranked probes (Methods S1 Figure IIIA). Additional optimization for different GC contents (Methods S1) shows that we can select probes from a whole-genome tiling array to accurately detect gene expression. To verify reproducibility of our analysis, we analyzed three samples, two asexual and one sporozoite in two technical replicates each, and obtained Pearson correlation coefficients of 0.986 to 0.996, indicating excellent reproducibility, whereas lower correlation is observed between samples from divergent asexual groups (Methods S1 Figure IIIB-D). Results were also confirmed by qRT-PCR, and compared to expressed sequence tags (ESTs), as described in Methods S1.

Genes involved in similar processes are co-expressed

We first sought to address our hypothesis that genes involved in similar processes would be co-expressed. We identified 4,326 differentially expressed genes using the cutoff of ANOVA p-value <0.05 and fold change (FC) >2 using the individual probe intensity values for each gene using just our data. Differentially expressed genes were clustered using ontology-based pattern identification (OPI), an algorithm previously used with P. falciparum and P. yoelii expression datasets [10] (Figure 1A). This algorithm begins with 2,002 lists of genes sharing a common gene ontology (GO) annotation, literature co-citation, or other annotated parasite-specific process, e.g., there are 38 genes known to be involved in DNA replication. For each group a representative expression profile vector is computed using E values from all conditions for all genes in the group. Then all of the 4,326 differentially expressed genes are ranked by the correlation coefficient calculated between the gene's expression vector and the representative expression profile vector. The algorithm then uses a correlation coefficient optimization routine and creates expression clusters that contain the largest number of genes with common annotation and high correlation. In the case of the GO process “DNA replication” a group of 60 genes is created which contains 11 of 38 annotated DNA replication genes. The probability of this distribution occurring by chance is less than 10−13. Similarly, there is less than 10−8 probability of identifying 5 of 15 genes with an annotation of glycolysis in a cluster of 21 genes. In addition to using gene ontologies we also used other groupings of genes. In a previous analysis of P. falciparum lifecycle stages [9] we had identified 106 genes upregulated in sporozoites, which corresponds to 66 P. vivax orthologs in our dataset (GO:CCYCL01). Of these 35 were found in a group of 366 genes with a probability of enrichment by chance of 10−20. Overall these data showed that patterns of gene expression were nonrandom and that genes with similar functions showed much greater cohesion than would be expected by chance. Altogether, 121 clusters of highly correlated genes with shared annotation were identified (see companion web site:

Previous analysis of P. vivax blood stage gene expression for parasites taken into synchronous short term culture has been performed [11] and we compared our results to these. Because this study involved two color microarrays and did not produce expression levels, direct comparisons between expression levels are not possible. However, we could still apply the same OPI clustering algorithm to the Bozdech data. Clustering of the Bozdech data (see companion web site) gave less information about sporozoites and sexual stages but revealed highly significant functional enrichments, especially within the area of protein biosynthesis and ribosome function, which is expected because of the higher sampling throughout the erythrocytic cycle. For example, 48 or the 58 annotated genes with a predicted role in cytosolic ribosome (GO:0022626) were found in a cluster of 126 genes, with a probability of enrichment by chances of 10−63. The data showed that in many cases the same genes that cluster with “cytosolic ribosome” in the Bozdech data also cluster with “small ribosomal subunit” in our data. The gene, PVX_084645, co-clusters with ribosomal genes in both cases and is listed as hypothetical but its P. falciparum ortholog, PF14_0360, is listed as an eukaryotic translation initiation factor 2A protein and thus its association with ribosomes is not surprising. PVX_101135, a hypothetical, clusters with ribosomal proteins in both cases. BLASTP (p = 1.3×10−35) shows a strong match to the yeast protein YOR091W, a protein of unknown function that associates with ribosomes that interacts with GTPase Rbg1p [20].

We also co-clustered Bozdech data with our data to generate more accurate predictions of gene function creating a set of 192 different clusters containing between 2 and 493 genes and p-values between 10−3 and 10−52 (Figure 1, Table S2). Many of our functional predictions can be cross-validated with previously published data sets. In particular we checked if the same function prediction can be made based on combined P. falciparum and P. yoelii data set, using either previously published OPI clusters [10] or an updated cluster set using the latest gene annotations. For each P. vivax cluster we ran permutation tests to see their P. falciparum orthologs form denser protein networks than what would be expected by chance using both published two hybrid data [21] and literature co-citation data [10]. In total, 75 of the 192 OPI clusters led to protein networks with a p-value less than 0.05 based on 1000 permutation simulations. For example, PVX_123920, a putative ubiquitin-activating enzyme e1 clusters with genes involved in the proteosome regulatory particle in both P. vivax and in P. falciparum and has two-hybrid support as well [21]. While there are numerous examples that can be derived from well-studied processes, the greatest value of this data is in supporting predictions for genes that may not be found in other model organisms. PVX_092415 and PVX_113830 cluster with genes involved in merozoite development in P. falciparum and in P. vivax (GO:GNF0218) and furthermore, are supported by two-hybrid interaction studies from P. falciparum (Figure 2). Likewise, PVX_000945 shows a similar pattern. The Toxoplasma gondii homolog of this protein has been isolated from rhoptries [22] as has, the Toxoplasma ortholog of PVX_113800, which also clusters with genes involved in merozoite development in P. falciparum. There are numerous examples from pre-erythrocytic stages as well. Of course, some caution must be used in evaluating the data because genes involved in two different processes may be co-expressed (e.g. DNA replication is occurring during gamete production) and yet be involved in relatively different processes. Nevertheless this clustering exercise gives functional predictions for the many uncharacterized genes found in an OPI cluster.

Figure 2
Network analysis.

Heterogeneity in patient blood stage samples

Having established the overall quality of the data we examined the groups of genes that were differentially expressed in any one stage. While our initial expectation was that patient-derived blood samples would be relatively homogenous, unexpectedly, we observed large differences in the expression profiles of asexual samples with the most pronounced differences observed in genes involved in glycolysis. While we found little or no differential expression of the first three enzymes of the pathway: hexokinase (PVX_114315), glucose-6-phosphate isomerase (PVX_084735) and 6-phophofructokinase (PVX_099200), the eight remaining glycolytic enzymes: fructose 1,6-bisphosphate aldolase (PVX_118255), triosephosphate isomerase (PVX_118495), glyceraldehyde-3-phosphate dehydrogenase (PVX_117321), phosphoglycerate kinase (PVX_099535), phosphoglycerate mutase (PVX_091640), enolase (PVX_095015), lactate dehydrogenase (PVX_116630) and pyruvate kinase (PVX_114445) all showed very strong differential expression between samples with some genes showing up to a 100-fold higher expression in some asexual samples relative to others (Figure 3). These last eight enzymes are among the top 1% when ranked by transcript abundance in vitro trophozoites of P. falciparum and are among the top 5% of P. vivax genes in some samples but not others (Figure 3). These differences are unlikely to occur by chance (p = 1.9×10−7 comparing P. vivax group 1 and group 2 defined in Figure 3 with a paired t-test). While the high glycolysis samples were the minority (two of eight), they were more similar to that described in Cui et al. Here 22,236 ESTs from P. vivax-infected Thai blood samples [12] were sequenced. Our data showed good Spearman rank correlation with the Thai EST numbers and showed that those samples with high glycolysis gene E values were most similar (r = 0.53) (Table 1 and Methods S1) to the Thai strain. While it may be that these expression differences are due to contamination with gametocytes [23] the presence of 0–10% contaminating gametocytes cannot mathematically explain why lactate dehydrogenase is present at ~3,300 units in two asexual samples and as low as 75 (almost indistinguishable from background) in others [24]. Furthermore, genes typically associated with gametocytogenesis (e.g. Pvs25, PVX_111175) are higher in the high glycolysis samples (CM12 and CM13). An alternative is that although morphologies looked similar, a substantially different proportion of early and late cell cycle stages were contained in high and low glycolysis samples. Genes typically associated with schizogony and invasion such as myosin motor proteins and reticulocyte binding proteins, transcribed later in the Bozdech erythrocytic cycle data, were expressed at higher levels in the low glycolysis samples (Figure 1). Despite this, glycolysis transcripts generally do not show 50–100 fold changes in expression levels throughout the in vitro erythrocytic cycle in P. falciparum cultured in vitro [8], [9] nor are such large fold changes observed with P. vivax cultured in vitro [11]. In addition, such a hypothesis would require the patient samples to have been tightly synchronized. While more samples will be need to be examined, the data raise an intriguing possibility that there may be differential regulation of metabolism in a subset of patient-derived samples as observed in P. falciparum patient–derived samples (Figure 3) [24].

Figure 3
Expression of metabolic genes in P. vivax asexual blood stage parasites.

Many of the same transcripts needed for early intrahepatocyte function in P. falciparum are upregulated in P. vivax sporozoites

The molecular determinants regulating hypnozoite formation and relapse are unknown. One hypothesis is that the hypnozoite is an early stage exo-erythrocytic form (EEF) that is arrested in development. If this hypothesis is correct, we would expect the transcriptional profile of P. vivax sporozoites to be similar to species that do not form hypnozoites. Thus, we compared our P. vivax sporozoite expression profile to a P. falciparum sporozoite sample and three P. yoelii sporozoite samples analyzed previously [25], [26]. Sporozoite transcriptome comparisons showed that P. vivax sporozoites are generally similar to P. yoelii and P. falciparum sporozoites with positively correlated expression of highly expressed genes (r = 0.5). Despite some species-specific differences, we observed similar expression for many P. vivax genes whose P. falciparum and P. yoelii orthologs were previously shown to be upregulated in sporozoites, including some of the most highly expressed genes in the P. vivax sample (Table 2): In addition to genes known to be upregulated in sporozoites such as the initiation factor UIS1, and the serine threonine phosphatase UIS2, the list contains a number of known candidates for pre-erythrocytic subunit vaccines including the apical membrane antigen 1 (AMA1) gene and the circumsporozoite protein (CSP). In addition there are genes whose disruption has led to genetically attenuated sporozoites that may eventually be used in whole organism vaccines, including the ortholog of P. falciparum etramp10.3 or UIS4 in P. yoelii [27], [28], UIS3 [29] and P52 [30]. From the set of genes upregulated in multiple species (Table S4) we identified a set of sporozoite conserved orthologous transcripts (SCOT) that were upregulated in multiple species but not yet annotated that may provide a list of possible candidates antigens for P. vivax pre-erythrocytic vaccines, or which when disrupted may yield genetically attenuated sporozoites.

Table 2
Most highly expressed P. vivax genes in the sporozoite stage.

There are also, of course, genes which are not found in P. falciparum that are upregulated in P. vivax sporozoites and may play some unique role in the biology of P. vivax or other hypnozoite-forming parasites. Examples from the sporozoite specific combined OPI cluster (GO:GNF0006) include up to 63 genes without P. falciparum orthologs. There are also some genes previously shown to be upregulated in P. falciparum sporozoites, but whose orthologs were downregulated or barely increased in P. vivax sporozoites or vice versa (Table S4). One ApiAP2 gene (PVX_090110) and two zinc finger proteins (PVX_099045, PVX_099045, PVX_081725), which often function as transcription factors, were downregulated as were several RNA binding proteins (PVX_098995, PVX_098995, PVX_100715) and several kinases including two serine/threonine protein kinases (PVX_081395, PVX_081395, PVX_002805), a FIKK calcium-dependent protein kinase (PVX_091755) and a MAP kinase (PVX_084965). Although some of these differences could be due to strain specific or sporozoite collection variation we were able to confirm these species-specific differences in gene expression for 19 genes using qRT-PCR (Table S5).

Genes upregulated in gamete/zygotes are mostly uncharacterized

The process of sexual development and meiosis are poorly characterized in many species. An expression profiles from the mix of macrogametes and zygotes (Table 1) derived from in vitro cultivation of fertilized patient-derived gametocytes showed upregulation of only a few characterized genes include those with roles in DNA replication, meiosis and chromatin structure (Table 3). The majority of strongly differentially expressed genes are uncharacterized, although many had been shown to be upregulated during induction of in vitro gametocytogenesis in P. falciparum [15]. As predicted, high expression of the P. vivax ortholog of Pvs25 (PVX_111175), the ookinete surface protein, is found in this stage. Another membrane protein gene, the ortholog of the Toxoplasma gondii PhIL1 (photosensitized INA-labeled protein 1) (PVX_081335), was among the most highly upregulated (>20-fold) in P. vivax gametes/zygotes. This protein associates with the cytoskeleton and is localized to the apical end of the plasma membrane [31] where it may function as an ookinete-specific surface protein for midgut invasion. The transcription factor high mobility group protein, HMGB2 (PVX_089520) is found among the top 20 genes expressed in this sample (See Table S1). It was shown to be a critical regulator of oocyst development and appears to activate genes that are most highly transcribed in gametocytes, but then stored and translated in ookinetes [32]. Interestingly, some of these uncharacterized proteins are also upregulated during meiosis in humans, such as the human orthologs of PVX_117890 [33]. An exceptionally large proportion of the genes upregulated in zygotes (Table 3) did not fall into clusters with enrichments of known genes, highlighting the problem of using “guilt by association” when the existing knowledge base is sparse.

Table 3
Genes showing the strongest probability of differential upregulation in zygotes.

Ookinete gene expression

Gene ontology-based OPI clustering revealed few annotated gene functions to be upregulated in ookinetes. This finding likely reflects the difficulty of obtaining sufficient quantities of this developmental stage for in vitro study. We found high expression of genes involved in chromatin (e.g. histones) and translation, potentially reflecting the fact that once the parasite reaches the midgut and forms an oocyst, thousands of rounds of DNA replication will likely commence. Genes specifically upregulated in oocysts were mostly uncharacterized. Ookinete surface protein genes such as the P. vivax ortholog of the CSP and TRAP-related protein (PVX_095475), previously shown to be essential for ookinete invasion [34], [35], the transmission-blocking target antigen Pfs230 (PVX_003905), a sexual stage antigen s48/45 domain containing protein (PVX_003900), the transmission blocking target antigen precursor Pfs48/45 (PVX_083235), showed modest levels of upregulation (<3-fold) in ookinetes relative to any other stage. In P. falciparum, transcripts for many of these peak in early stage gametocytogenesis [15], and thus high expression would not necessarily be expected in P. vivax ookinetes, even if protein is detected in present.

On the other hand there were a number of uncharacterized genes that showed substantial upregulation in ookinetes (>3-fold). These may encode the proteins that are needed for early oocyst formation. Some examples (see Table S1 for details) include a possible calcium dependent kinase, (PVX_083525), and 5-aminolevulinic acid synthase (PVX_101195), a key enzyme in the porphyrin synthesis pathway that leads to heme synthesis. Proteases and other degradative enzymes may be needed to exit the blood meal, penetrate the peritrophic matrix or form the oocyst on the mosquito midgut. A number of proteases were unregulated in ookinetes, including Ulp1 (ubiquitin-like protein-specific protease, PVX_100650), which is specifically required for cell cycle progression in other species.

Drug resistance gene expression

While in many cases drug resistance in malaria parasites is conferred by single nucleotide polymorphisms [36][38], in some cases transcript amplification events in a target or in a pump [39] confer greater tolerance to drugs. We therefore compared levels of drug resistance gene transcripts to determine if anything interesting might be found. Most genes involved in drug resistance such as pvcrt (chloroquine resistance transporter, PVX_087980), dhps (dihydropteroate synthase, PVX_123230), gtpch (GTP cyclohydrolase, PVX_123830) or mdr1 (multidrug resistance gene 1, PVX_080100) showed similar patterns in P. vivax and P. falciparum. An exception was dihydrofolate reductase (dhfr, PVX_089950), the target of the widely used antimalarial antifolate drug, pyrimethamine. Remarkably, dhfr expression was 50-fold higher in the India VII P. vivax sporozoites (confirmed by qRT-PCR, see Table S6) and 10-fold to 30-fold higher in P. vivax asexual stages compared to P. falciparum, where it was near background in all stages. Interestingly, while P. falciparum is sensitive to pyrimethamine, P. vivax is considered intrinsically resistant [40], although in vitro drug sensitivity data is not available for most P. vivax strains. Both dhfr mutations [41], [42] and amplifications [43] have been shown to confer resistance in P. falciparum. Thus, the higher dhfr expression in P. vivax relative to P. falciparum may confer higher tolerance to pyrimethamine.

vir genes show lower than average expression

While much of our data shows that patterns of gene expression are conserved across Plasmodium species the data also reveals possible roles for information about the many uncharacterized genes which are specific to P. vivax including members of multigene families. The largest paralogous gene family of P. vivax is the diverse superfamily of variant surface protein genes (vir) found in subtelomeric regions [44] and may be related to the rif genes of P. falciparum and yir genes of P. yoelii [45]. The highly variable surface protein var gene family in P. falciparum has no orthologs in P. vivax. Expression levels for most of the 274 vir genes on the array were lower than for other genes. The average for vir genes was 210 units (approximately the 35th percentile) using the highest value in any one stage (MaxExp in Supplemental Table 1), versus 572 units (approximately the 80th percentile) on average for other genes. In addition 39 of the 109 genes in the genome, which were not detected as differentially expressed in any sample, were vir genes. Only 27 of the 274 probed vir genes showed strong differential regulation (>5-fold change, p ANOVA<0.001) versus 1,044 of the remaining 5,420 genes. Interestingly, four of the highest expressed vir genes (PVX_086860, PVX_096970, PVX_096980, PVX_096985) were among the highest expressed genes in the two high glycolysis asexual samples, indicating possible alternate mechanisms of expression control. Three of these highly expressed vir genes are adjacent to one another suggesting coordinated regulation of the entire region. Cui et al. also found these three vir genes and another gene in the same region (PVX_096975) had the highest numbers of ESTs in their patient samples [12].

Most highly expressed members of multigene families are co-transcribed with exported proteins

Malaria parasites are known to be able to decorate the surface of infected erythrocytes with proteins that play roles in sequestration and immune evasion. Many of the exported proteins contain sequences, called PEXEL or VPS motifs that direct them out of the parasitophorous vacuole and to the surface [46], [47] and many are members of multigene families, presumably because enhanced levels of recombination between members or epigenetic transcriptional switching between members allows the parasite to evade the host immune responses to these exposed proteins. Many of the exported genes in P. falciparum are transcribed at specific, mid-trophozoite stages of the parasite cell cycle [47]. The number of predicted exported proteins in P. vivax is not as large as in P. falciparum most likely due to problems in recognizing PEXEL/VPS motifs in this species. For example, only 160 of the 346 vir proteins contain predicted export motifs [48]. In addition to vir genes the 20 members of the P. vivax PHIST (Plasmodia helical interspersed subtelomeric) exported gene family (Pv-fam-b)[49] on the array are expected to be exported as well as some members of the Pv-fam-h and Pv-fam-e families.

Remarkably many of the members of the multigene families as well as most predicted exported proteins that show strong differential transcription show peak expression in just one of our blood stage samples, CM115 (Figure 4). Five of the eight exported PHIST genes, six of the ten of Pv-fam-e family of RAD GTPases (some exported), nine of the 11, Pv-fam-d, and 9 or the 11 Pv-fam-a genes that show strong (>5X) differential expression again peak mostly in CM115. While vir genes show lower levels of expression overall, many of those that are differentially expressed also peak in CM115. Notably, 17 of the 38 expressed above 300 units show peak transcript levels in sample CM115. Many of the genes showing dramatic upregulation (up to 100 fold) in sample CM115 are abundantly transcribed. The Pv-fam-d family with 16 genes of unknown function has 2 genes in the top 1% of all genes ranked by maximum expression as does the Pv-fam-a family of tryptophan rich antigens (PvTRAg, average max expression in any one sample  = 1,969 units). One P. vivax tryptophan-rich antigen, PvTRAg (PVX_090265), has shown a very high seropositivity rate for the presence of antibodies in P. vivax malaria patients [50]. Another highly immunogenic antigen in this multigene family is PvATRAg74 (PVX_101510), recombinant versions of which showed erythrocyte binding activity and were recognized by all P. vivax patient sera tested [51]. This gene also ranks in the top 1% of transcripts in CM115. Many of the exported genes in P. falciparum are transcribed at specific, mid-trophozoite stages of the parasite cell cycle [47] and it seems likely that most of the parasites in asexual sample CM115 are at this export permissive stage. Thus many of the genes that are specifically upregulated in CM115 may play a role in immune evasion. While genes involved in DNA replication are also upregulated in CM115, these same genes are also upregulated in zygotes, while those encoding exported proteins may not be. These data nicely illustrate how the random collections of gene expression data that may be obtained from a neglected parasite can be used to create high quality predictions if enough random and yet diverse data is available. The data also illustrate that an advantage of using P. vivax patient samples is that a high level of synchrony may exist, that is confirmed by the Bozdech data (Figure 4).

Figure 4
Co-expression of members of multigene families.

Of course members of multigene families that share sequence similarity may have different cellular roles depending on their expression in the parasite lifecycle. An example is the group of cysteine protease genes referred to as serine repeat antigens (SERAs). In P. falciparum, PFB0325c, one of the seven SERA genes is expressed in sporozoites, while the others are expressed in blood stages. Disruption of this SERA ortholog, called ECP1 in P. berghei, results in parasites that are unable to migrate out of the oocyst[52]. Although P. vivax contains 13 SERA cysteine protease paralogs, only the ECP1 ortholog (PVX_003790) was dramatically upregulated in sporozoites (105X). Two others showed substantial upregulation in sample CM12. None of the SERAs show maximal expression in sample CM115, nor do any members of the Pv-fam-c, homologous to the SURFIN gene family in P. falciparum. These are not appreciably expressed in any of our samples and may be functioning in other life stages.

Exploring transcriptional regulatory circuits

In many organisms, including Plasmodium species, genes that are co-expressed share common sequence motifs in the regions upstream of their translational start sites [16]. To determine whether this would be true in P. vivax we looked for enriched motifs in various OPI groupings created with our data or the combined larger dataset. Here all possible 6–9 mers are counted within a group of co-expressed genes and these numbers are compared to the number found in all upstream regions. A corrected p-value that accounts for the multiple testing hypothesis is then computed. In general we find that transcriptional control is conserved and that many of the same motifs, which appear to control gene expression in P. falciparum also appear to control gene expression in P. vivax. For example an unbiased search for overrepresented sequences upstream of the 70 sporozoite-specific genes with promoter sequences (GO:GNF0006) relative to upstream regions in the whole genome found a motif similar to one associated with P. falciparum sporozoite genes. This putative regulatory sequence, TGCATG, is found upstream of 44 of the 70 P. vivax sporozoite-specific OPI cluster genes. The corrected probability of enrichment by chance in this set relative to the rest of the upstream regions in the genome is 0.02. Additionally, 48 of 65 genes in the list of SCOT genes contained the TGCATG motif (Table S6, p = 9.16×10−7). This is similar to the PfM24.1 sporozoite-specific regulatory motif CATGCAG identified in P. falciparum [16], sharing the core CATGC sequence and identical to the sequence (Table S6) bound by the P. falciparum ApiAP2 transcription factor PF14_0633 [53]. The P. yoelii ortholog of this transcription factor (PY00247) is among the highest expressed genes in midgut sporozoites [10], supporting the hypothesis that this protein functions as a specific activator of sporozoite transcription [25].

A rich variety of other promoter motifs could be found by searching the various other OPI clusters as well. The sequence TGTAnnTACA was found enriched in the 1000 bases upstream of 383 genes from an OPI cluster containing 12 of the 19 genes mentioned in a an analysis of P. falciparum sexual development (GO:PM16005087, 92/364 genes, p = 1.69×10−26). This motif (Figure 5) is identical to the motif that is found in 65 of the 246 genes upregulated during sexual development in P. falciparum [15]. A cluster of genes enriched for ones with a role in gliding motility gave the motif TGTnnACA (86 or 155 genes, p = 0.00224). A search of a cluster with many genes predicted to be involved in merozoite development (GO:GNF0218) produced the motif GTGCA in 392 of 443 genes with a probability of enrichment by chance of 4.31×10−13. Protein binding microarrays have shown that the P. falciparum AP2 transcription factor, PFF0200c binds this motif [53]. It is also found upstream of P. falciparum genes transcribed during schizogony [16]. As with P. falciparum [54] the sequence CACAC was enriched in a cluster of genes containing an abundance of DNA replication genes (GO:0030894, 192 of 228 promoter regions, p = 4.7×10−6). Novel motifs were also found. A cluster enriched for genes identified in a male gametes (GO:PM16115694 [55]) yielded the motif CGTACA in 35 of 66 genes (p = 0.0645) and the sequence GCTATGC was found upstream of 36 of the 105 genes with promoter sequences in the cluster containing many of the structural constituents of the ribosome (GO:0003735, p = 0.007). This motif is similar to binding site for the AP2-O transcription factor (TAGCTA) that functions as a positive regulator of ookinete gene expression [56]. While these motifs may not be the same, expression of ribosomal proteins is upregulated in ookinete stages and one must keep in mind that transcription factor binding is likely to be combinatorial and a given gene may have multiple regulatory sites contained within its upstream region.

Figure 5
Sequence motifs associated with stage specific-expression.


Analysis of the transcriptome of blood stages and sporozoites of P. vivax shows that the general mechanisms of growth, development, metabolism, and host-parasite interactions are shared by all Plasmodium species. Some of the expression differences that exist between species may provide insight into the molecular and genetic basis of biological differences that distinguish the species. The most significant differences include the formation of hypnozoites by P. vivax, pathogenic processes of sequestration and antigenic variation, and the wider geographical distribution of P. vivax into temperate regions. However, examination of a much larger number of different strains will probably be need to determine which differences of the differences we find are likely to be due to speciation and which are due to strain or experiment variability.

Because of the difficulties of working with P. vivax, transcriptional and proteomic studies represent one of the most effective ways to find candidate genes for vaccines or other processes. Many of the genes that cluster with proven antigens for pre-erythrocytic vaccines such as CSP may be worth investigating especially if sera drawn from individuals living in P. vivax endemic regions shows cross reactivity to their cognate protein [57]. A high-throughput analysis P. falciparum proteomic data [58] revealed one exceptionally abundant sporozoite protein named Ag2 in P. falciparum [59] or CelTos in P. berghei [60], which was more immunogenic than previously identified antigens such as CSP. In P. falciparum this is the third most abundant transcript in sporozoites. Ag2 one of the few antigens that is able to provide cross-species immunity and indeed we also find it highly expressed in our sporozoite sample. Given that many of the SCOT genes show strong expression only in sporozoite stages, their disruption may lead to genetically attenuated sporozoites that cannot develop in the liver, but which nevertheless provide immunity.

The gamete/zygote and ookinete expression data provides insight into mosquito midgut biology of a second human-infecting malaria parasite, and confirms common stage-specific gene expression shared by multiple Plasmodium species. Processes of sexual development, meiosis and DNA replication were evident in the gamete/zygote transcriptome. Some ookinete surface protein genes show highest expression in the gamete/zygote stage. Ookinetes produce stage-specific surface proteins, secreted proteases and invasion-related gliding motility proteins. While we observe upregulation of many cell-surface genes involved in invasion in our gametes/zygotes and ookinetes relative to asexual stages, this conclusion should be considered in light of the fact that our asexual stage gene expression represented ring and trophozoite stages, but no schizont and merozoite stage gene expression, thus biasing the analysis against the invasive blood stage parasites.

The function of the vir gene family is still unknown, but published data seems to indicate its function is fundamentally different from var genes. While P. falciparum var genes display mutually exclusive expression only during the mature stages [61], different vir [11], yir [62] and rif [63] genes are expressed in different intra-erythrocytic stages and gametocytes [64]. Previous studies showed that vir expression is not clonal, and multiple vir subfamilies are expressed in individual parasites from infected patients [65]. This is supported by our analysis of vir expression in vivo, with high-level expression of a small subset of vir genes in the high glycolysis samples along with other genes such as the PvTRAG genes that are likely involved in antigenic variation and immune evasion. However, examination of our data will also show that expression levels for many vir genes was very low or not detectable, indicated that they may be silenced. It is formally possibly that none of the parasites that we collected were at a stage where vir genes are being actively transcribed, potentially because of sequestration. The overall low levels could also be attributed to having mixed stage parasites in our samples, however many other cell-cycle regulated genes such as histones showed strong (>50) fold differential expression in some of our blood stage samples. Finally, vir gene genetic differences between the genome reference strain, Salvador I, and the Peruvian samples [66] could contribute to reduced expression levels, although high expression was certainly found for other members of variable gene families. Excepting these caveats, our data are consistent with a model in which some vir genes are transcriptionally-silenced.

The OPI analysis here provides functional predictions for a large numbers of genes. However, its limitation is that it uses existing knowledge and it is likely that interesting clusters of genes may be of mixed function, which can be estimated by examining the false positive and true positive rates in each cluster in Supplemental Table 2. In some cases the functional enrichment may be misleading and thus caution should be used in interpreting the labels. Many of the exported protein and blood stage antigens are found in an OPI cluster named “ribonuclease activity” reflecting the fact that this is the only well-annotated cellular process going on at this time. Finally, 501 of the differentially expressed genes were not contained in any of the OPI clusters. This may be because they are playing a role as ookinete, oocyst or hypnozoite function. Traditional hierarchical or k-means clustering is likely the best way to find out the function of these genes (see companion web site). Finally, 296 were not considered differentially expressed. Some of these may be upregulated in liver or oocyst sporozoite stages or they may be silenced.

One of the more remarkable things about the gene expression analysis is its robustness and insensitivity to sample contamination or admixture. Our group contained few samples focused on early sexual stage parasites and only a single zygote sample and yet we were able to extract groups of genes from which we could extract a sexual development transcription factor motif. Of course, the fact that we had no oocyst salivary gland sporozoite or liver stages means that this dataset is not comprehensive and more work will need to be done. While P. vivax is by no means a model organisms the gene expression data described here may be more useful for discovering motifs involved in regulating transcription as the lower AT content may be less problematic. It should also be noted that successes were not dependent on having the larger structured Bozdech dataset as many of the motifs could be extracted from the OPI clusters created with our data alone. A group of genes enriched for those with roles in sexual development (GO:PM16005087) could be extracted from our data when clustered independently (7 of the 19 genes in a group of 172, p = 10−5) and could be used in motif finding. However no groups of genes enriched for ones with roles in sexual development were found when the Bozdech data was analyzed independently (See Supplemental Table 2). However, when the datasets were combined, the quality of the cluster improved (12 of the 19 genes in a group of 246, p = 10−8) even though the Bozdech samples were not predicted to contain sexual stage parasites. Thus, more data and diversity is better.

These gene expression data for in vivo patient infections, gametes/zygotes, ookinetes and sporozoites of the P. vivax parasite provide an important foundation and reference for future studies. Numerous differences in gene expression suggest many hypotheses to be tested by researchers in the laboratory and in the field, and may be used to guide drug treatment and vaccine development for P. vivax. Further studies may provide correlations between in vivo parasite gene expression variability between patient samples and phenotypes of disease severity and drug resistance. In combination with accurate drug treatment outcomes and patient data, we will begin to identify the key determinants of the host-parasite interactions in this important pathogen.

Supporting Information

Methods S1

Supplemental methods.

(0.81 MB DOC)

Table S1

Gene expression and ANOVA for all P. vivax genes.

(2.79 MB XLS)

Table S2

OPI clusters. Gene Ontology based OPI cluster summary and gene lists for Westenberger, Bozdech and merged datasets, each contained in different sheets.

(8.87 MB XLS)

Table S3

Annotation for newly predicted P. vivax genes.

(0.06 MB XLS)

Table S4

SCOT, UVS, DVS, and P. vivax-specific sporozoite gene lists and expression values.

(0.07 MB XLS)

Table S5

Quantitative RT-PCR values for differentially expressed sporozoite genes.

(0.04 MB XLS)

Table S6

Position and sequence of the putative regulatory motif in upstream regions of sporozoite-specific genes.

(0.07 MB XLS)


The authors would like to thank the staff of PlasmoDB for help and support for accessing information for comparative genomic analysis. Paula Maguina of the University of California San Diego made essential contributions in terms of ethics management and international coordination and logistical support for this project.


The authors have declared that no competing interests exist.

SJW was supported by NIH grant 1F32AI074242-01A1. JMC was supported by NIH grant R01GM070793. JMV and CMM were supported by NIH grants 1K24AI068903 and 1R01AI067727. Funding from Medicines for Malaria Venture and the Wellcome Trust supported these studies and SLH. EAW was supported by the Keck Foundation and NIH grant R01AI059472-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009;9:555–566. [PubMed]
2. Rogerson SJ, Carter R. Severe vivax malaria: newly recognised or rediscovered. PLoS Med. 2008;5:e136. [PubMed]
3. Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis. 2009;22:430–435. [PubMed]
4. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008;5:e128. [PubMed]
5. Contacos PG, Collins WE, Jeffery GM, Krotoski WA, Howard WA. Studies on the characterization of plasmodium vivax strains from Central America. Am J Trop Med Hyg. 1972;21:707–712. [PubMed]
6. Yount EH, Jr, Coggeshall LT. Status of immunity following cure of recurrent vivax malaria. Am J Trop Med Hyg. 1949;29:701–705. [PubMed]
7. Pfahler JM, Galinski MR, Barnwell JW, Lanzer M. Transient transfection of Plasmodium vivax blood stage parasites. Mol Biochem Parasitol. 2006;149:99–101. [PubMed]
8. Bozdech Z, Llinas M, Pulliam BL, Wong ED, Zhu J, et al. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol. 2003;1:85–100. [PMC free article] [PubMed]
9. Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, et al. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science. 2003;301:1503–1508. [PubMed]
10. Zhou Y, Ramachandran V, Kumar KA, Westenberger S, Refour P, et al. Evidence-Based Annotation of the Malaria Parasite's Genome Using Comparative Expression Profiling. PLoS ONE. 2008;3:e1570. [PMC free article] [PubMed]
11. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, et al. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci U S A. 2008;105:16290–16295. [PubMed]
12. Cui L, Fan Q, Hu Y, Karamycheva SA, Quackenbush J, et al. Gene discovery in Plasmodium vivax through sequencing of ESTs from mixed blood stages. Mol Biochem Parasitol. 2005;144:1–9. [PubMed]
13. Barrera L, Benner C, Tao YC, Winzeler E, Zhou Y. Leveraging two-way probe-level block design for identifying differential gene expression with high-density oligonucleotide arrays. BMC Bioinformatics. 2004;5:42. [PMC free article] [PubMed]
14. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc. 2007;2:2366–2382. [PMC free article] [PubMed]
15. Young JA, Fivelman QL, Blair PL, de la Vega P, Le Roch KG, et al. The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification. Mol Biochem Parasitol. 2005;143:67–79. [PubMed]
16. Young JA, Johnson JR, Benner C, Yan SF, Chen K, et al. In silico discovery of transcription regulatory elements in Plasmodium falciparum. BMC Genomics. 2008;9:70. [PMC free article] [PubMed]
17. Zhou Y, Young JA, Santrosyan A, Chen K, Yan SF, et al. In silico gene function prediction using ontology-based pattern identification. Bioinformatics. 2005;21:1237–1245. [PubMed]
18. Sullivan JS, Strobert E, Yang C, Morris CL, Galland GG, et al. Adaptation of a strain of Plasmodium vivax from India to New World monkeys, chimpanzees, and anopheline mosquitoes. J Parasitol. 2001;87:1398–1403. [PubMed]
19. Dharia NV, Sidhu AB, Cassera MB, Westenberger SJ, Bopp SE, et al. Use of high-density tiling microarrays to globally identify mutations and elucidate mechanisms of drug resistance in Plasmodium falciparum. Genome Biol. 2009;10:R21. [PMC free article] [PubMed]
20. Fleischer TC, Weaver CM, McAfee KJ, Jennings JL, Link AJ. Systematic identification and functional screens of uncharacterized proteins associated with eukaryotic ribosomal complexes. Genes Dev. 2006;20:1294–1307. [PubMed]
21. LaCount DJ, Vignali M, Chettier R, Phansalkar A, Bell R, et al. A protein interaction network of the malaria parasite Plasmodium falciparum. Nature. 2005;438:103–107. [PubMed]
22. Bradley PJ, Ward C, Cheng SJ, Alexander DL, Coller S, et al. Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J Biol Chem. 2005;280:34245–34258. [PubMed]
23. Lemieux JE, Gomez-Escobar N, Feller A, Carret C, Amambua-Ngwa A, et al. Statistical estimation of cell-cycle progression and lineage commitment in Plasmodium falciparum reveals a homogeneous pattern of transcription in ex vivo culture. Proc Natl Acad Sci U S A. 2009;106:7559–7564. [PubMed]
24. Daily JP, Scanfeld D, Pochet N, Le Roch K, Plouffe D, et al. Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature. 2007;450:1091–1095. [PubMed]
25. Le Roch KG, Johnson JR, Florens L, Zhou Y, Santrosyan A, et al. Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res. 2004;14:2308–2318. [PubMed]
26. Kumar KA, Garcia CR, Chandran VR, Van Rooijen N, Zhou Y, et al. Exposure of Plasmodium sporozoites to the intracellular concentration of potassium enhances infectivity and reduces cell passage activity. Mol Biochem Parasitol. 2007;156:32–40. [PubMed]
27. Matuschewski K, Ross J, Brown SM, Kaiser K, Nussenzweig V, et al. Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage. J Biol Chem. 2002;277:41948–41953. [PubMed]
28. Mueller AK, Camargo N, Kaiser K, Andorfer C, Frevert U, et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A. 2005;102:3022–3027. [PubMed]
29. Mueller AK, Labaied M, Kappe SH, Matuschewski K. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature. 2005;433:164–167. [PubMed]
30. van Dijk MR, Douradinha B, Franke-Fayard B, Heussler V, van Dooren MW, et al. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci U S A. 2005;102:12194–12199. [PubMed]
31. Gilk SD, Raviv Y, Hu K, Murray JM, Beckers CJ, et al. Identification of PhIL1, a novel cytoskeletal protein of the Toxoplasma gondii pellicle, through photosensitized labeling with 5-[125I]iodonaphthalene-1-azide. Eukaryot Cell. 2006;5:1622–1634. [PMC free article] [PubMed]
32. Gissot M, Ting LM, Daly TM, Bergman LW, Sinnis P, et al. High Mobility Group Protein HMGB2 Is a Critical Regulator of Plasmodium Oocyst Development. J Biol Chem. 2008;283:17030–17038. [PMC free article] [PubMed]
33. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004;101:6062–6067. [PubMed]
34. Dessens JT, Beetsma AL, Dimopoulos G, Wengelnik K, Crisanti A, et al. CTRP is essential for mosquito infection by malaria ookinetes. EMBO J. 1999;18:6221–6227. [PubMed]
35. Yuda M, Sakaida H, Chinzei Y. Targeted disruption of the plasmodium berghei CTRP gene reveals its essential role in malaria infection of the vector mosquito. J Exp Med. 1999;190:1711–1716. [PMC free article] [PubMed]
36. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000;6:861–871. [PMC free article] [PubMed]
37. Peterson DS, Walliker D, Wellems TE. Evidence that a point mutation in dihydrofolate-reductase thymidylate synthase confers resistance to pyrimethamine in falciparum-malaria. Proc Natl Acad Sci U S A. 1988;85:9114–9118. [PubMed]
38. Brooks DR, Wang P, Read M, Watkins WM, Sims PFG, et al. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase - dihydropteroate synthase gene in-line so the human malaria parasite, Plasmodium-falciparum, with differing resistance to sulfadoxine. Eur J Biochem. 1994;224:397–405. [PubMed]
39. Wilson CM, Serrano AE, Wasley A, Bogenschutz MP, Shankar AH, et al. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science. 1989;244:1184–1186. [PubMed]
40. Young MD, Burgess RW. Pyrimethamine resistance in Plasmodium vivax malaria. Bull World Health Organ. 1959;20:27–36. [PubMed]
41. Gregson A, Plowe CV. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev. 2005;57:117–145. [PubMed]
42. Peterson DS, Walliker D, Wellems TE. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci U S A. 1988;85:9114–9118. [PubMed]
43. Thaithong S, Ranford-Cartwright LC, Siripoon N, Harnyuttanakorn P, Kanchanakhan NS, et al. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine. Exp Parasitol. 2001;98:59–70. [PubMed]
44. del Portillo HA, Fernandez-Becerra C, Bowman S, Oliver K, Preuss M, et al. A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature. 2001;410:839–842. [PubMed]
45. Janssen CS, Phillips RS, Turner CM, Barrett MP. Plasmodium interspersed repeats: the major multigene superfamily of malaria parasites. Nucleic Acids Res. 2004;32:5712–5720. [PMC free article] [PubMed]
46. Hiller NL, Bhattacharjee S, van Ooij C, Liolios K, Harrison T, et al. A host-targeting signal in virulence proteins reveals a secretome in malarial infection. Science. 2004;306:1934–1937. [PubMed]
47. Marti M, Good RT, Rug M, Knuepfer E, Cowman AF. Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science. 2004;306:1930–1933. [PubMed]
48. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008;455:757–763. [PMC free article] [PubMed]
49. Sargeant TJ, Marti M, Caler E, Carlton JM, Simpson K, et al. Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites. Genome Biol. 2006;7:R12. [PMC free article] [PubMed]
50. Jalah R, Sarin R, Sud N, Alam MT, Parikh N, et al. Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax. Mol Biochem Parasitol. 2005;142:158–169. [PubMed]
51. Alam MT, Bora H, Singh N, Sharma YD. High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74). Vaccine. 2008;26:3787–3794. [PubMed]
52. Aly AS, Matuschewski K. A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. J Exp Med. 2005;202:225–230. [PMC free article] [PubMed]
53. De Silva EK, Gehrke AR, Olszewski K, Leon I, Chahal JS, et al. Specific DNA-binding by apicomplexan AP2 transcription factors. Proc Natl Acad Sci U S A. 2008;105:8393–8398. [PubMed]
54. Elemento O, Slonim N, Tavazoie S. A universal framework for regulatory element discovery across all genomes and data types. Mol Cell. 2007;28:337–350. [PMC free article] [PubMed]
55. Kooij TW, Franke-Fayard B, Renz J, Kroeze H, van Dooren MW, et al. Plasmodium berghei alpha-tubulin II: a role in both male gamete formation and asexual blood stages. Mol Biochem Parasitol. 2005;144:16–26. [PubMed]
56. Yuda M, Iwanaga S, Shigenobu S, Mair GR, Janse CJ, et al. Identification of a transcription factor in the mosquito-invasive stage of malaria parasites. Mol Microbiol. 2009;71:1402–1414. [PubMed]
57. Doolan DL, Mu Y, Unal B, Sundaresh S, Hirst S, et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics. 2008;8:4680–4694. [PMC free article] [PubMed]
58. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, et al. A proteomic view of the Plasmodium falciparum life cycle. Nature. 2002;419:520–526. [PubMed]
59. Doolan DL, Southwood S, Freilich DA, Sidney J, Graber NL, et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci U S A. 2003;100:9952–9957. [PubMed]
60. Kariu T, Ishino T, Yano K, Chinzei Y, Yuda M. CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Mol Microbiol. 2006;59:1369–1379. [PubMed]
61. Scherf A, Hernandez-Rivas R, Buffet P, Bottius E, Benatar C, et al. Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum. EMBO J. 1998;17:5418–5426. [PubMed]
62. Cunningham D, Fonager J, Jarra W, Carret C, Preiser P, et al. Rapid changes in transcription profiles of the Plasmodium yoelii yir multigene family in clonal populations: lack of epigenetic memory? PLoS ONE. 2009;4:e4285. [PMC free article] [PubMed]
63. Petter M, Haeggstrom M, Khattab A, Fernandez V, Klinkert MQ, et al. Variant proteins of the Plasmodium falciparum RIFIN family show distinct subcellular localization and developmental expression patterns. Mol Biochem Parasitol. 2007;156:51–61. [PubMed]
64. Petter M, Bonow I, Klinkert MQ. Diverse expression patterns of subgroups of the rif multigene family during Plasmodium falciparum gametocytogenesis. PLoS ONE. 2008;3:e3779. [PMC free article] [PubMed]
65. Fernandez-Becerra C, Pein O, de Oliveira TR, Yamamoto MM, Cassola AC, et al. Variant proteins of Plasmodium vivax are not clonally expressed in natural infections. Mol Microbiol. 2005;58:648–658. [PubMed]
66. Merino EF, Fernandez-Becerra C, Durham AM, Ferreira JE, Tumilasci VF, et al. Multi-character population study of the vir subtelomeric multigene superfamily of Plasmodium vivax, a major human malaria parasite. Mol Biochem Parasitol. 2006;149:10–16. [PubMed]

Articles from PLoS Neglected Tropical Diseases are provided here courtesy of Public Library of Science